AccessibilityHelpAbout Us
Olympus logo

Olympus(OTC) OLYMY

Market Cap$13.58BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1995)+503%
5 Year-38%
1 Year+4%
1 Month-6%
$12.78
-1.31%
-0.17Today
Olympus last closing stock price
MetricPriceDate
Last closeUSD 12.782026-09-18
Olympus stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.16%USD 12.802026-09-11
1 month-6.03%USD 13.602026-08-19
3 month+23.96%USD 10.312026-06-18
Year to date+2.91%USD 12.422025-12-31
1 year+4.06%USD 12.282025-09-18
3 year-5.4%USD 13.512023-09-19
5 year-38.24%USD 20.692021-09-17
Since inception+502.87%USD 2.121995-09-28

Olympus Financials at a Glance

Market Cap

$13.58BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

¥1.06T

Net Income (TTM)

¥79.25B

EPS (TTM)

$0.46

P/E Ratio

27.70

Dividend

$0.19

Beta (Volatility)

0.56 (Low)

Price

$12.78

Volume

48,606

Open

$12.68

Previous Close

$12.78

Daily Range

$12.68 - $12.78

52-Week Range

$8.08 - $13.73

Estimated Earnings Date

Nov 6, 2026

OLYMY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Olympus

Olympus Corporation is a global enterprise specializing in the production and distribution of sophisticated machinery and instrumentation. Founded in Tokyo, Japan, in 1919, the company operates across four divisions: Endoscopic Solutions, Therapeutic Solutions, Scientific Solutions, and Others. Olympus is recognized for its innovative medical devices and equipment, particularly in the healthcare sector.

Products and Services
  • Endoscopic devices for gastrointestinal and surgical applications
  • Microscopy equipment and industrial endoscopes
  • Biomedical-grade materials and orthopedic apparatus
Growth Outlook
  • Revenue of 224.5 billion JPY in Q3 2022, showing stability
  • Operating income margin improved to 24.7% in Q3 2022
  • Net income of 36.1 billion JPY reflects strong profitability
Financial Highlights
  • Trailing twelve months (TTM) revenue of 883.3 billion JPY
  • Net profit margin of 7.5% indicates effective cost management
  • Dividend yield of 1.5% offers attractive returns to shareholders
Olympus Corporation continues to demonstrate resilience and growth potential in the medical devices industry. The company's diverse product offerings and strong financial performance position it well for future opportunities. With a focus on innovation and quality, Olympus remains a key player in the healthcare sector, appealing to investors seeking exposure to this dynamic market.
AI Generated • Sep 20, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

28,138

CEO

Robert White, MBA

Website

www.olympus.co.jp

Headquarters

Hachioji, TY 192-8507, JP

OLYMY Financials

Key Financial Metrics (TTM)

Gross Margin

64.70%

Operating Margin

15.88%

Net Income Margin

7.49%

Return on Equity

10.21%

Return on Capital

9.59%

Return on Assets

5.13%

Earnings Yield

3.61%

Dividend Yield

1.46%

Payout Ratio

42.20%

Stock Overview

Market Cap

$13.58BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.06B

Volume

48.61K

Avg. Volume

55.43K

Financials (TTM)

Gross Profit

¥684.37B

Operating Income

¥156.11B

EBITDA

¥212.18B

Operating Cash Flow

¥134.42B

Capital Expenditure

-¥59.16B

Free Cash Flow

¥75.25B

Cash & ST Invst.

¥151.18B

Total Debt

¥316.79B

Olympus Performance Analysis

Olympus annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31JPY 6,510,441,449-2.5%
20242024-03-31JPY 6,410,429,033-1.5%
20252025-03-31JPY 6,542,011,1542.1%
20262026-03-31JPY 6,706,895,0592.5%
Olympus sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-3020.3%
Q32025-12-317.2%
Q42026-03-3113.2%
Q12026-06-30-19.0%
Olympus annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31JPY 0.834.0%
20242024-03-31JPY 1.3865.4%
20252025-03-31JPY 0.67-51.2%
20262026-03-31JPY 0.41-39.8%
Olympus sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-30127.6%
Q32025-12-31-27.6%
Q42026-03-3171.2%
Q12026-06-30-20.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

¥243.57B

+18.2%

Gross Profit

¥158.89B

+17.9%

Gross Margin

65.24%

N/A

Market Cap

$13.58BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$482.72K

N/A

Employees

28,138

N/A

Net Income

¥19.35B

+115.7%

EBITDA

¥49.75B

+71.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

¥151.18B

-38.4%

Total Debt

¥316.79B

+14.6%

Accounts Receivable

¥218.36B

+10.9%

Inventory

¥219.85B

+8.2%

Long Term Debt

¥178.58B

-22.8%

Short Term Debt

¥138.21B

+207.6%

Return on Assets

5.13%

N/A

Return on Invested Capital

15.66%

N/A

Free Cash Flow

-¥1.94B

+93.1%

Operating Cash Flow

¥14.52B

+195.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ESALYEisai Co., Ltd.
$61.51-2.11%
ODTCOdonate Therapeutics, Inc.
$22,005.00+29.44%
BITGFBiotage AB (publ)
$15.01+0.00%
VTEQVeriTeQ Corporation
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$152.71-1.36%
NVDANvidia
$222.27+1.34%
AGNCAGNC Investment Corp.
$9.87-0.40%
INTCIntel
$108.60-0.18%

Questions About OLYMY

What is the current price of Olympus?

Olympus is trading at $12.78 per share.

What is the 52-week range for Olympus?

Over the past 52 weeks, Olympus has traded between $8.08 and $13.73.

How much debt does Olympus have?

As of the most recent reporting period, Olympus reported total debt of ¥1.96B.

How much cash does Olympus have on hand?

Olympus reported ¥729.40M in cash and cash equivalents in its most recent financial results.

What is Olympus’s dividend yield?

Olympus currently has a dividend yield of 1.46%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services